CN1886132A - 用作降压药的卡维地洛和其它β阻断剂的硝基氧基衍生物 - Google Patents

用作降压药的卡维地洛和其它β阻断剂的硝基氧基衍生物 Download PDF

Info

Publication number
CN1886132A
CN1886132A CNA200480035459XA CN200480035459A CN1886132A CN 1886132 A CN1886132 A CN 1886132A CN A200480035459X A CNA200480035459X A CN A200480035459XA CN 200480035459 A CN200480035459 A CN 200480035459A CN 1886132 A CN1886132 A CN 1886132A
Authority
CN
China
Prior art keywords
integer
chemical compound
diastereomer
enantiomer
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA200480035459XA
Other languages
English (en)
Chinese (zh)
Inventor
P·德尔索尔达托
F·贝内迪尼
E·安吉尼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nicox SA
Original Assignee
Nicox SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox SA filed Critical Nicox SA
Publication of CN1886132A publication Critical patent/CN1886132A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C219/14—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C219/06—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having the hydroxy groups esterified by carboxylic acids having the esterifying carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/30—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
    • C07C233/33—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CNA200480035459XA 2003-12-02 2004-12-01 用作降压药的卡维地洛和其它β阻断剂的硝基氧基衍生物 Pending CN1886132A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03104484 2003-12-02
EP03104484.5 2003-12-02

Publications (1)

Publication Number Publication Date
CN1886132A true CN1886132A (zh) 2006-12-27

Family

ID=34639309

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA200480035459XA Pending CN1886132A (zh) 2003-12-02 2004-12-01 用作降压药的卡维地洛和其它β阻断剂的硝基氧基衍生物

Country Status (22)

Country Link
US (1) US7825263B2 (cg-RX-API-DMAC7.html)
EP (1) EP1691804B1 (cg-RX-API-DMAC7.html)
JP (1) JP2007513114A (cg-RX-API-DMAC7.html)
KR (1) KR20060120677A (cg-RX-API-DMAC7.html)
CN (1) CN1886132A (cg-RX-API-DMAC7.html)
AR (1) AR047732A1 (cg-RX-API-DMAC7.html)
AT (1) ATE358478T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004294297A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0416584A (cg-RX-API-DMAC7.html)
CA (1) CA2548129A1 (cg-RX-API-DMAC7.html)
DE (1) DE602004005748T2 (cg-RX-API-DMAC7.html)
DK (1) DK1691804T3 (cg-RX-API-DMAC7.html)
ES (1) ES2285549T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20070283T3 (cg-RX-API-DMAC7.html)
IL (1) IL174959A0 (cg-RX-API-DMAC7.html)
NO (1) NO20063057L (cg-RX-API-DMAC7.html)
PL (2) PL380065A1 (cg-RX-API-DMAC7.html)
PT (1) PT1691804E (cg-RX-API-DMAC7.html)
RU (1) RU2006119528A (cg-RX-API-DMAC7.html)
SI (1) SI1691804T1 (cg-RX-API-DMAC7.html)
WO (1) WO2005053685A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200604458B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115246774A (zh) * 2021-04-27 2022-10-28 南昌弘益科技有限公司 一类新型双羰基类阿魏酸衍生物

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE437637T1 (de) 2001-05-02 2009-08-15 Nitromed Inc Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren
WO2007090733A1 (en) * 2006-02-06 2007-08-16 Nicox S.A. Nitrooxy derivatives suitable as alpha2 adrenergic receptor agonists
CA2641501A1 (en) 2006-02-06 2007-08-16 Nicox S.A. Nitrooxy-comprising derivatives of apraclonidine and brimodnidine as al pha2 -adrenergic receptor agonists
WO2008112287A1 (en) 2007-03-12 2008-09-18 Nektar Therapeutics Oligomer-beta blocker conjugates
JP2010527401A (ja) 2007-05-14 2010-08-12 タイコ ヘルスケア グループ リミテッド パートナーシップ 抗菌材料および被膜
US8062653B2 (en) * 2009-02-18 2011-11-22 Bezwada Biomedical, Llc Controlled release of nitric oxide and drugs from functionalized macromers and oligomers
US11420995B2 (en) 2017-03-03 2022-08-23 Synovo Gmbh Anti-infective and anti-inflammatory compounds

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2805404A1 (de) * 1978-02-09 1979-08-16 Merck Patent Gmbh 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung
DE3443998A1 (de) * 1984-12-01 1986-06-05 Boehringer Mannheim Gmbh, 6800 Mannheim Amino-propanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
DE3512627A1 (de) * 1985-04-06 1986-10-09 Boehringer Mannheim Gmbh, 6800 Mannheim Amino-propanol-derivate, verfahren zu deren herstellung, verwendung derselben und diese enthaltende arzneimittel
ES2065291B1 (es) * 1993-07-30 1995-10-01 Prodesfarma Sa "nitrato esteres de 1-ariloxi-3-alquilamino-2-propanoles, utilizacion y composicion farmaceutica correspondiente"
US5932538A (en) * 1996-02-02 1999-08-03 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
IT1295694B1 (it) 1996-11-14 1999-05-27 Nicox Sa Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica
PE20001302A1 (es) * 1998-11-27 2000-11-30 Hoffmann La Roche Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida
IT1311924B1 (it) * 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
IT1311923B1 (it) * 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
IT1314184B1 (it) * 1999-08-12 2002-12-06 Nicox Sa Composizioni farmaceutiche per la terapia di condizioni di stressossidativo
EP1385509A4 (en) * 2001-04-02 2004-06-30 Smithkline Beecham Corp TREATMENT METHOD
DE60222131D1 (de) * 2001-05-28 2007-10-11 Chemtech Res Inc Neues alkaloidderivat und dieses enthaltende pharmazeutische zusammensetzung
ITMI20020148A1 (it) * 2002-01-29 2003-07-29 Nicox Sa Nuovi corticosteroidi

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115246774A (zh) * 2021-04-27 2022-10-28 南昌弘益科技有限公司 一类新型双羰基类阿魏酸衍生物

Also Published As

Publication number Publication date
US20070072854A1 (en) 2007-03-29
ZA200604458B (en) 2007-04-25
DK1691804T3 (da) 2007-07-16
PL380065A1 (pl) 2006-12-11
EP1691804A1 (en) 2006-08-23
HRP20070283T3 (en) 2007-11-30
DE602004005748D1 (de) 2007-05-16
KR20060120677A (ko) 2006-11-27
US7825263B2 (en) 2010-11-02
WO2005053685A1 (en) 2005-06-16
ES2285549T3 (es) 2007-11-16
SI1691804T1 (sl) 2007-10-31
JP2007513114A (ja) 2007-05-24
IL174959A0 (en) 2006-08-20
BRPI0416584A (pt) 2007-01-30
PT1691804E (pt) 2007-07-04
AR047732A1 (es) 2006-02-15
ATE358478T1 (de) 2007-04-15
AU2004294297A1 (en) 2005-06-16
PL1691804T3 (pl) 2007-08-31
DE602004005748T2 (de) 2007-12-27
NO20063057L (no) 2006-06-30
RU2006119528A (ru) 2008-01-10
EP1691804B1 (en) 2007-04-04
CA2548129A1 (en) 2005-06-16

Similar Documents

Publication Publication Date Title
CN1024667C (zh) 取代的氨甲基四氢化萘和取化氨甲基氢化苯并吡喃及其盐制备方法
CN1144799C (zh) N-(亚氨基甲基)胺衍生物,其制备方法,其作为药物的用途以及含有该化合物的药物组合物
CN1538967A (zh) 杂环化合物和以其为有效成分的抗肿瘤药
CN1090281A (zh) 具有抗糖尿病和抗肥胖症性质的噁唑烷衍生物,它们的制备和它们在治疗方面的用途
CN1109054A (zh) 噁唑烷-2-酮衍生物
CN1906159A (zh) 前列腺素硝基氧衍生物
CN1035178C (zh) 芳酰胺衍生物
CN1246315C (zh) 氨基烷基苯甲酰基-苯并呋喃或苯并噻吩类,它们的制备方法与含有它们的组合物
CN1203587A (zh) 新的杂环衍生物及其医药用途
CN1077954A (zh) 新的苯并吡喃衍生物
CN1032751C (zh) 噻唑烷化合物,其制备及其治疗用途
CN86104787A (zh) 制备聚-4-氨基吡咯-2-甲酰胺基衍生物的方法
CN1423637A (zh) 新的取代的三环化合物
CN1147469C (zh) 带有芳香族含氮杂环的新型脲衍生物
CN1027536C (zh) 4,5,6,7-四氢化苯并咪唑衍生物制备方法
CN1071665A (zh) 唑烷酮衍生物
CN1254334A (zh) 新颖的对苯二甲酰胺衍生物
CN1167707C (zh) 作为细胞粘连抑制剂的单糖的2,3-o-异亚丙基衍生物
CN85101425A (zh) 带有次苯基的斯伯格埃林有关化合物及其制备方法
CN1590379A (zh) 新的杂环肟化合物、它们的制备方法和含有它们的药物组合物
CN1708491A (zh) N-苯并间二氧杂环戊烯基、n-苯并二噁烷基和n-苯并二氧杂䓬基芳基甲酰胺衍生物以及包含它们的药物组合物
CN1183907C (zh) 新的咪唑啉化合物、其制备方法和含有它们的药物组合物
CN1662519A (zh) 新化合物及其作为甘氨酸转运抑制剂的用途
CN1047860A (zh) 丁烯酸衍生物
CN1148378C (zh) 15-脱氧精胍林类似物、其制备方法及其治疗应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1102002

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1102002

Country of ref document: HK